No Data
No Data
What Assure Tech (Hangzhou) Co., Ltd.'s (SHSE:688075) P/E Is Not Telling You
Anxu Bio (688075.SH): Over 90% of the company's sales in overseas markets in 2023.
On July 8th, Gelon Hui announced that Anxu Biology (688075.SH) stated on the investor interaction platform that the company's sales model is mainly focused on overseas sales, and overseas market sales will account for more than 90% of the company's total sales in 2023.
Anxu Bio (688075.SH) will distribute a cash dividend of 0.4 yuan per share for the year 2023 on July 9th.
Anxu Bio (688075.SH) announced that it will distribute the 2023 annual cash dividend on July 9, 2024 ...
Assure Tech (Hangzhou) (SHSE:688075) Could Be Struggling To Allocate Capital
Anxu Biotech (688075.SH): Net profit in 2023 fell 95.34% year on year
Gelonghui, Feb. 28, 丨 An Xu Biotech (688075.SH) announced its 2023 annual performance report. During the reporting period, the company achieved operating income of 508.2998 million yuan, a decrease of 91.76% over the same period of the previous year; realized net profit attributable to owners of the parent company of 141.7741 million yuan, a decrease of 95.34% over the same period last year; realized net profit attributable to owners of the parent company after deducting non-recurring profit and loss of 52.44,800 yuan, a decrease of 98.24% from the same period last year.
Insiders Are the Top Stockholders in Assure Tech (Hangzhou) Co., Ltd. (SHSE:688075), and the Recent 13% Drop Might Have Disappointed Them
No Data